An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone kept a daily weight log for about two weeks while using semaglutide and shared the numbers. The entries show a starting weight around 120.8 kg (about 266 pounds) at the end of July and small day-to-day changes down to about 118 kg by mid‑August. The post is basically a short progress snapshot — not a formal study — showing modest weight loss over roughly two weeks. Semaglutide is the active drug in medicines you’ve probably heard of, like Ozempic and Wegovy. It’s a man‑made version of a hormone your gut releases after you eat. That hormone talks to your brain to reduce appetite, makes you feel full sooner, and slows how quickly your stomach empties. Doctors use semaglutide to treat type 2 diabetes and, at higher doses, for long‑term weight management. What this log actually shows is very limited but concrete: small, gradual drops in weight over a short period in one person. The numbers go up and down a little from day to day — that’s normal because hydration, recent meals, and bathroom use change the scale reading. The overall change reported is a few kilograms over a couple of weeks, which is plausible for someone starting semaglutide, but this is just one anecdote. There’s no control group, no information about diet or activity, and no way to separate drug effect from other factors. Why it matters is straightforward: people considering semaglutide for weight loss look for real-world evidence of how quickly it works. This log suggests you might see small progress within weeks, which can feel encouraging. Clinicians and people thinking about treatment should treat such posts as one small data point rather than proof. If someone is tracking their own progress, daily logs can be motivating, but expect natural fluctuations. There are important caveats. A short, single-person weight log can’t tell you about long-term success, safety, or side effects. Common side effects of semaglutide include nausea, diarrhea, constipation, and sometimes injection-site reactions. It can interact with other medical conditions and drugs, and it isn’t appropriate for everyone (for example, people with certain thyroid cancers or a history of pancreatitis need to be cautious). Semaglutide is a prescription medication and should be used under medical supervision. Bottom line: this weight log shows modest early weight loss that’s consistent with what people starting semaglutide might experience, but it’s only one person’s short-term snapshot and not evidence of how well the drug works or how safe it will be for you.
Source: r/Semaglutide